Dow Up 0.69% Nasdaq Down 0.32%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
6.42 Down 0.03(0.39%) 11:07AM EDT - Nasdaq Real Time Price
Prev Close:6.44
Open:6.43
Bid:6.40 x 200
Ask:6.41 x 100
1y Target Est:27.67
Beta:-1.05
Next Earnings Date:10-Nov-14RPRX Earnings announcement
Day's Range:6.34 - 6.49
52wk Range:5.92 - 22.57
Volume:105,815
Avg Vol (3m):1,207,190
Market Cap:148.24M
P/E (ttm):N/A
EPS (ttm):-1.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RPRX

Comparison

Symbol% ChgMkt Cap
RPRXDown 0.39%148.24M
ABTUp 0.61%64.66B
ACTUp 0.17%63.21B
AUXLDown 0.16%1.60B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.53
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback